CRISPR Therapeutics AG (CRSP)
USD 32.23
(-1.32%)
USD 32.23
(-1.32%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.22 Billion USD | -0.6% |
| 2022 | 2.24 Billion USD | -18.49% |
| 2021 | 2.75 Billion USD | 50.54% |
| 2020 | 1.82 Billion USD | 71.36% |
| 2019 | 1.06 Billion USD | 118.14% |
| 2018 | 489.01 Million USD | 80.22% |
| 2017 | 271.34 Million USD | -21.34% |
| 2016 | 344.96 Million USD | 116.38% |
| 2015 | 159.42 Million USD | 10340.28% |
| 2014 | 1.52 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.43 Billion USD | 9.39% |
| 2024 Q3 | 2.25 Billion USD | -3.58% |
| 2024 Q2 | 2.33 Billion USD | -4.07% |
| 2023 Q2 | 2.19 Billion USD | -2.11% |
| 2023 FY | 2.22 Billion USD | -0.6% |
| 2023 Q1 | 2.24 Billion USD | 0.06% |
| 2023 Q4 | 2.22 Billion USD | 6.84% |
| 2023 Q3 | 2.08 Billion USD | -5.02% |
| 2022 Q1 | 2.6 Billion USD | -5.29% |
| 2022 FY | 2.24 Billion USD | -18.49% |
| 2022 Q4 | 2.24 Billion USD | -4.69% |
| 2022 Q3 | 2.35 Billion USD | -4.47% |
| 2022 Q2 | 2.46 Billion USD | -5.48% |
| 2021 Q3 | 2.82 Billion USD | -2.68% |
| 2021 FY | 2.75 Billion USD | 50.54% |
| 2021 Q2 | 2.89 Billion USD | 48.09% |
| 2021 Q1 | 1.95 Billion USD | 7.11% |
| 2021 Q4 | 2.75 Billion USD | -2.48% |
| 2020 Q2 | 1.04 Billion USD | 3.89% |
| 2020 Q3 | 1.48 Billion USD | 41.9% |
| 2020 Q4 | 1.82 Billion USD | 23.09% |
| 2020 FY | 1.82 Billion USD | 71.36% |
| 2020 Q1 | 1 Billion USD | -5.57% |
| 2019 Q4 | 1.06 Billion USD | 48.04% |
| 2019 FY | 1.06 Billion USD | 118.14% |
| 2019 Q2 | 494.24 Million USD | -0.73% |
| 2019 Q3 | 720.59 Million USD | 45.8% |
| 2019 Q1 | 497.87 Million USD | 1.81% |
| 2018 Q3 | 518.9 Million USD | 46.94% |
| 2018 Q4 | 489.01 Million USD | -5.76% |
| 2018 FY | 489.01 Million USD | 80.22% |
| 2018 Q1 | 374.45 Million USD | 38.0% |
| 2018 Q2 | 353.13 Million USD | -5.69% |
| 2017 FY | 271.34 Million USD | -21.34% |
| 2017 Q1 | 322.34 Million USD | -6.56% |
| 2017 Q2 | 304.97 Million USD | -5.39% |
| 2017 Q3 | 282.31 Million USD | -7.43% |
| 2017 Q4 | 271.34 Million USD | -3.89% |
| 2016 Q2 | 293.05 Million USD | 20.96% |
| 2016 Q1 | 242.26 Million USD | 51.97% |
| 2016 FY | 344.96 Million USD | 116.38% |
| 2016 Q4 | 344.96 Million USD | 23.8% |
| 2016 Q3 | 278.65 Million USD | -4.92% |
| 2015 Q4 | 159.42 Million USD | 0.0% |
| 2015 FY | 159.42 Million USD | 10340.28% |
| 2014 FY | 1.52 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AbCellera Biologics Inc. | 1.48 Billion USD | -49.827% |
| Alkermes plc | 2.13 Billion USD | -4.37% |
| Agenus Inc. | 313.91 Million USD | -610.251% |
| Alnylam Pharmaceuticals, Inc. | 3.82 Billion USD | 41.785% |
| Aptorum Group Limited | 20.64 Million USD | -10702.137% |
| Ardelyx, Inc. | 297.57 Million USD | -649.237% |
| Arrowhead Pharmaceuticals, Inc. | 765.55 Million USD | -191.237% |
| Bicycle Therapeutics plc | 595.34 Million USD | -274.501% |
| BioXcel Therapeutics, Inc. | 73.7 Million USD | -2925.116% |
| ChromaDex Corporation | 54.96 Million USD | -3956.421% |
| Chimerix, Inc. | 212.77 Million USD | -947.859% |
| Corbus Pharmaceuticals Holdings, Inc. | 28.27 Million USD | -7786.036% |
| Caribou Biosciences, Inc. | 440.96 Million USD | -405.608% |
| Precision BioSciences, Inc. | 159.78 Million USD | -1295.392% |
| Dyadic International, Inc. | 8.21 Million USD | -27026.256% |
| Eton Pharmaceuticals, Inc. | 31.74 Million USD | -6924.483% |
| Fortress Biotech, Inc. | 167.52 Million USD | -1230.881% |
| Lantern Pharma Inc. | 43.64 Million USD | -5008.116% |
| HOOKIPA Pharma Inc. | 161.33 Million USD | -1281.934% |
| Inhibikase Therapeutics, Inc. | 14.5 Million USD | -15269.306% |
| Incyte Corporation | 6.78 Billion USD | 67.126% |
| IO Biotech, Inc. | 150.71 Million USD | -1379.3% |
| Jaguar Health, Inc. | 50.76 Million USD | -4292.118% |
| Novavax, Inc. | 1.85 Billion USD | -20.17% |
| Janux Therapeutics, Inc. | 380.4 Million USD | -486.101% |
| Opthea Limited | 188.79 Million USD | -1080.972% |
| Ligand Pharmaceuticals Incorporated | 833.06 Million USD | -167.635% |
| ContextLogic Inc. | 423 Million USD | -427.085% |
| MiMedx Group, Inc. | 239.04 Million USD | -832.691% |
| Pyxis Oncology, Inc. | 173.72 Million USD | -1183.384% |
| TransCode Therapeutics, Inc. | 5.16 Million USD | -43027.659% |
| NextCure, Inc. | 129.41 Million USD | -1622.767% |
| Ocuphire Pharma, Inc. | 53.94 Million USD | -4032.815% |
| Oncternal Therapeutics, Inc. | 36.72 Million USD | -5970.329% |
| Outlook Therapeutics, Inc. | 32.3 Million USD | -6802.483% |
| Vaxcyte, Inc. | 1.4 Billion USD | -58.36% |
| PDS Biotechnology Corporation | 59.39 Million USD | -3654.113% |
| Madrigal Pharmaceuticals, Inc. | 640.54 Million USD | -248.073% |
| Pharming Group N.V. | 462.85 Million USD | -381.701% |
| Pieris Pharmaceuticals, Inc. | 38.68 Million USD | -5664.144% |
| Avidity Biosciences, Inc. | 628.55 Million USD | -254.714% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -11681.913% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -11681.913% |
| Sangamo Therapeutics, Inc. | 165.32 Million USD | -1248.64% |
| Sol-Gel Technologies Ltd. | 45.28 Million USD | -4823.203% |
| Acelyrin, Inc. | 742.69 Million USD | -200.202% |
| Salarius Pharmaceuticals, Inc. | 6.58 Million USD | -33750.5% |
| SELLAS Life Sciences Group, Inc. | 6.4 Million USD | -34720.725% |
| Summit Therapeutics Inc. | 202.94 Million USD | -998.587% |
| Sensei Biotherapeutics, Inc. | 74.37 Million USD | -2897.783% |
| Senti Biosciences, Inc. | 119.48 Million USD | -1766.0% |
| Stoke Therapeutics, Inc. | 228.34 Million USD | -876.417% |
| Syros Pharmaceuticals, Inc. | 168.17 Million USD | -1225.752% |
| Alaunos Therapeutics, Inc. | 8.26 Million USD | -26882.585% |
| Telomir Pharmaceuticals, Inc. Common Stock | 4.77 Million USD | -46604.637% |
| Entrada Therapeutics, Inc. | 469.19 Million USD | -375.194% |
| VistaGen Therapeutics, Inc. | 123.65 Million USD | -1703.087% |
| Wave Life Sciences Ltd. | 274.94 Million USD | -710.903% |
| Sorrento Therapeutics, Inc. | 472.84 Million USD | -371.528% |
| TRACON Pharmaceuticals, Inc. | 10.1 Million USD | -21964.038% |
| Barinthus Biotherapeutics plc | 214.5 Million USD | -939.398% |
| Psyence Biomedical Ltd. | 1.13 Million USD | -196830.908% |
| Phathom Pharmaceuticals, Inc. | 413.84 Million USD | -438.749% |
| Immix Biopharma, Inc. | 19.92 Million USD | -11089.727% |
| Keros Therapeutics, Inc. | 370.02 Million USD | -502.546% |
| MEI Pharma, Inc. | 41.37 Million USD | -5288.691% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -6780.118% |
| Xeris Biopharma Holdings, Inc. | 340.79 Million USD | -554.221% |
| Rigel Pharmaceuticals, Inc. | 117.22 Million USD | -1801.959% |
| Fortress Biotech, Inc. | 167.52 Million USD | -1230.881% |
| Precigen, Inc. | 151.04 Million USD | -1376.117% |
| Clearside Biomedical, Inc. | 34.01 Million USD | -6454.092% |
| AlloVir, Inc. | 190.79 Million USD | -1068.563% |
| C4 Therapeutics, Inc. | 376.45 Million USD | -492.261% |
| Fate Therapeutics, Inc. | 506.21 Million USD | -340.438% |
| ImmuCell Corporation | 43.8 Million USD | -4989.403% |
| IDEAYA Biosciences, Inc. | 649.31 Million USD | -243.372% |
| Onconetix, Inc. | 88.82 Million USD | -2410.172% |
| PureTech Health plc | 693.97 Million USD | -221.276% |
| VYNE Therapeutics Inc. | 97.68 Million USD | -2182.409% |
| Elevation Oncology, Inc. | 89.09 Million USD | -2402.577% |
| Kintara Therapeutics, Inc. | 6.2 Million USD | -35849.226% |
| Seer, Inc. | 436.26 Million USD | -411.054% |
| Verrica Pharmaceuticals Inc. | 81.59 Million USD | -2632.418% |
| Innoviva, Inc. | 1.24 Billion USD | -79.297% |
| Aadi Bioscience, Inc. | 132.42 Million USD | -1583.674% |
| ESSA Pharma Inc. | 149.12 Million USD | -1395.131% |
| GlycoMimetics, Inc. | 45.31 Million USD | -4820.001% |
| GT Biopharma, Inc. | 14.1 Million USD | -15702.474% |
| Inhibrx Biosciences, Inc. | 307.89 Million USD | -624.138% |
| Akebia Therapeutics, Inc. | 241.7 Million USD | -822.442% |
| Catalyst Pharmaceuticals, Inc. | 471.9 Million USD | -372.46% |
| Longboard Pharmaceuticals, Inc. | 50.69 Million USD | -4297.836% |
| Orchestra BioMed Holdings, Inc. | 95.21 Million USD | -2241.691% |
| Alzamend Neuro, Inc. | 631.58 Thousand USD | -352910.349% |
| Rocket Pharmaceuticals, Inc. | 566.34 Million USD | -293.68% |
| Aptose Biosciences Inc. | 12.92 Million USD | -17153.344% |
| ZyVersa Therapeutics, Inc. | 22.11 Million USD | -9982.04% |
| Soligenix, Inc. | 9.79 Million USD | -22656.934% |
| Century Therapeutics, Inc. | 360.69 Million USD | -518.139% |
| Kura Oncology, Inc. | 448.93 Million USD | -396.636% |
| TScan Therapeutics, Inc. | 272.14 Million USD | -719.246% |
| Intensity Therapeutics, Inc. | 17.29 Million USD | -12791.419% |
| Ocean Biomedical, Inc. | 110.91 Million USD | -1910.228% |
| CytomX Therapeutics, Inc. | 205.15 Million USD | -986.795% |
| Autolus Therapeutics plc | 375.38 Million USD | -493.949% |
| Mineralys Therapeutics, Inc. | 251.63 Million USD | -786.03% |
| EyePoint Pharmaceuticals, Inc. | 355.18 Million USD | -527.723% |
| Eterna Therapeutics Inc. | 49.13 Million USD | -4437.92% |
| Adaptive Biotechnologies Corporation | 661.13 Million USD | -237.234% |
| GRI Bio, Inc. | 2.95 Million USD | -75325.271% |
| Xenetic Biosciences, Inc. | 10.6 Million USD | -20923.324% |
| Tenaya Therapeutics, Inc. | 170.51 Million USD | -1207.551% |
| IGM Biosciences, Inc. | 423.41 Million USD | -426.574% |
| INmune Bio, Inc. | 57 Million USD | -3811.459% |
| Heron Therapeutics, Inc. | 222.5 Million USD | -902.027% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -2556.109% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -8436.904% |
| Entero Therapeutics, Inc. | 6.88 Million USD | -32291.513% |
| Milestone Pharmaceuticals Inc. | 75.22 Million USD | -2863.83% |
| X4 Pharmaceuticals, Inc. | 147.25 Million USD | -1414.058% |
| Atara Biotherapeutics, Inc. | 165.5 Million USD | -1247.14% |
| Coherus BioSciences, Inc. | 629.6 Million USD | -254.123% |
| Verastem, Inc. | 149.71 Million USD | -1389.18% |
| Abeona Therapeutics Inc. | 64 Million USD | -3383.596% |
| Pliant Therapeutics, Inc. | 512.15 Million USD | -335.332% |
| Tonix Pharmaceuticals Holding Corp. | 154.45 Million USD | -1343.49% |
| Histogen Inc. | 19.07 Million USD | -11589.671% |
| Aprea Therapeutics, Inc. | 22.65 Million USD | -9743.505% |
| Surrozen, Inc. | 46.08 Million USD | -4738.479% |
| Organovo Holdings, Inc. | 6.34 Million USD | -35016.885% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -51646.754% |
| Ovid Therapeutics Inc. | 144.02 Million USD | -1448.025% |
| Panbela Therapeutics, Inc. | 11.8 Million USD | -18791.468% |
| CASI Pharmaceuticals, Inc. | 75.26 Million USD | -2862.176% |
| Cadrenal Therapeutics, Inc. Common Stock | 8.51 Million USD | -26070.977% |
| Centessa Pharmaceuticals plc | 362.96 Million USD | -514.259% |
| Hepion Pharmaceuticals, Inc. | 18.09 Million USD | -12221.886% |
| Arcturus Therapeutics Holdings Inc. | 429.4 Million USD | -419.227% |
| BioRestorative Therapies, Inc. | 12.61 Million USD | -17578.564% |
| Apollomics, Inc. | 55.38 Million USD | -3925.441% |
| Amarin Corporation plc | 831.68 Million USD | -168.079% |
| Mesoblast Limited | 669.15 Million USD | -233.193% |
| Turnstone Biologics Corp. | 112.81 Million USD | -1876.307% |
| Kymera Therapeutics, Inc. | 575.75 Million USD | -287.24% |
| Synaptogenix, Inc. | 31.11 Million USD | -7065.89% |
| Tiziana Life Sciences Ltd | 12.18 Million USD | -18199.171% |
| Aurinia Pharmaceuticals Inc. | 548.06 Million USD | -306.81% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -37867.846% |
| Monopar Therapeutics Inc. | 7.34 Million USD | -30254.292% |
| Exelixis, Inc. | 2.94 Billion USD | 24.225% |
| Better Therapeutics, Inc. | 22.94 Million USD | -9617.87% |
| Nurix Therapeutics, Inc. | 364.53 Million USD | -511.614% |
| Apellis Pharmaceuticals, Inc. | 788.73 Million USD | -182.679% |
| NLS Pharmaceutics AG | 1.84 Million USD | -120636.57% |
| Dermata Therapeutics, Inc. | 7.97 Million USD | -27844.27% |
| Aridis Pharmaceuticals, Inc. | 14.69 Million USD | -15072.31% |
| Gritstone bio, Inc. | 177.76 Million USD | -1154.196% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -2237.567% |
| TNF Pharmaceuticals, Inc. | 17.86 Million USD | -12382.014% |
| Avid Bioservices, Inc. | 336.55 Million USD | -562.465% |
| Insmed Incorporated | 1.32 Billion USD | -67.657% |
| Virpax Pharmaceuticals, Inc. | 9.62 Million USD | -23056.326% |
| MediWound Ltd. | 66.45 Million USD | -3254.807% |
| OmniAb, Inc. | 401.98 Million USD | -454.64% |
| Alector, Inc. | 621.82 Million USD | -258.552% |
| Seres Therapeutics, Inc. | 358.6 Million USD | -521.743% |
| Checkpoint Therapeutics, Inc. | 5.37 Million USD | -41357.252% |
| Viracta Therapeutics, Inc. | 56.69 Million USD | -3832.779% |
| Zai Lab Limited | 1.03 Billion USD | -115.148% |
| Revance Therapeutics, Inc. | 478.45 Million USD | -365.995% |
| Aura Biosciences, Inc. | 255.07 Million USD | -774.084% |
| Lyell Immunopharma, Inc. | 750.02 Million USD | -197.265% |
| Immunic, Inc. | 54.29 Million USD | -4006.1% |
| Tarsus Pharmaceuticals, Inc. | 266.22 Million USD | -737.479% |
| Veracyte, Inc. | 1.13 Billion USD | -95.951% |
| InMed Pharmaceuticals Inc. | 11.82 Million USD | -18758.26% |
| FibroGen, Inc. | 423.52 Million USD | -426.427% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -63366.297% |
| Adial Pharmaceuticals, Inc. | 4.73 Million USD | -46971.077% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.42 Million USD | -40964.187% |
| Jazz Pharmaceuticals plc | 11.39 Billion USD | 80.431% |
| Cyclacel Pharmaceuticals, Inc. | 8.8 Million USD | -25221.647% |
| Amylyx Pharmaceuticals, Inc. | 517.45 Million USD | -330.873% |
| TG Therapeutics, Inc. | 329.58 Million USD | -576.474% |
| Galecto, Inc. | 38.22 Million USD | -5732.451% |
| Calithera Biosciences, Inc. | 28.67 Million USD | -7675.042% |
| Fortrea Holdings Inc. | 4.35 Billion USD | 48.83% |
| KalVista Pharmaceuticals, Inc. | 235.4 Million USD | -847.125% |
| Aptevo Therapeutics Inc. | 24.84 Million USD | -8875.006% |
| XBiotech Inc. | 227.24 Million USD | -881.14% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -2237.567% |
| Lyra Therapeutics, Inc. | 142.6 Million USD | -1463.514% |
| Foghorn Therapeutics Inc. | 285.91 Million USD | -679.799% |
| Y-mAbs Therapeutics, Inc. | 127.86 Million USD | -1643.637% |
| Theravance Biopharma, Inc. | 381.99 Million USD | -483.659% |
| Ultragenyx Pharmaceutical Inc. | 1.49 Billion USD | -49.534% |
| Metagenomi, Inc. Common Stock | 364.84 Million USD | -511.106% |
| Vaxxinity, Inc. | 44.35 Million USD | -4926.878% |
| BioCryst Pharmaceuticals, Inc. | 516.96 Million USD | -331.285% |
| Gain Therapeutics, Inc. | 18.6 Million USD | -11880.93% |
| Cartesian Therapeutics, Inc. | 305.05 Million USD | -630.887% |
| NexImmune, Inc. | 8.59 Million USD | -25843.498% |
| Creative Medical Technology Holdings, Inc. | 10.71 Million USD | -20707.573% |
| Marker Therapeutics, Inc. | 17.12 Million USD | -12917.575% |
| Regeneron Pharmaceuticals, Inc. | 33.08 Billion USD | 93.26% |
| Chemomab Therapeutics Ltd. | 22.15 Million USD | -9965.269% |
| Scopus BioPharma Inc. | 392.26 Thousand USD | -568283.873% |
| RAPT Therapeutics, Inc. | 173.32 Million USD | -1186.323% |
| Ainos, Inc. | 31.84 Million USD | -6902.025% |
| Pluri Inc. | 39.52 Million USD | -5540.628% |
| Prothena Corporation plc | 696.38 Million USD | -220.165% |
| Adaptimmune Therapeutics plc | 282.61 Million USD | -688.905% |
| Celularity Inc. | 143.88 Million USD | -1449.508% |
| Rallybio Corporation | 115.62 Million USD | -1828.361% |
| Cue Biopharma, Inc. | 61.53 Million USD | -3523.551% |
| MeiraGTx Holdings plc | 458.16 Million USD | -386.627% |
| Omeros Corporation | 378.26 Million USD | -489.414% |
| Humacyte, Inc. | 128.22 Million USD | -1638.823% |
| Immunocore Holdings plc | 597 Million USD | -273.462% |
| Cocrystal Pharma, Inc. | 31.25 Million USD | -7032.573% |
| Cidara Therapeutics, Inc. | 68.53 Million USD | -3153.423% |
| Blueprint Medicines Corporation | 1.04 Billion USD | -112.492% |
| CalciMedica, Inc. | 12.18 Million USD | -18197.669% |
| Cabaletta Bio, Inc. | 253.65 Million USD | -778.995% |
| Marinus Pharmaceuticals, Inc. | 170.9 Million USD | -1204.545% |
| Scholar Rock Holding Corporation | 311.03 Million USD | -616.823% |
| Sana Biotechnology, Inc. | 565.29 Million USD | -294.406% |
| Pulmatrix, Inc. | 33.95 Million USD | -6465.672% |
| Elicio Therapeutics, Inc. | 27.14 Million USD | -8113.258% |
| Vigil Neuroscience, Inc. | 140.85 Million USD | -1482.85% |
| Intellia Therapeutics, Inc. | 1.3 Billion USD | -71.377% |
| Adlai Nortye Ltd. American Depositary Shares | 130.18 Million USD | -1612.564% |
| Cytokinetics, Incorporated | 824.31 Million USD | -170.475% |
| Eloxx Pharmaceuticals, Inc. | 21.12 Million USD | -10455.182% |
| Nutriband Inc. | 7.51 Million USD | -29559.775% |
| Protara Therapeutics, Inc. | 78.95 Million USD | -2723.886% |
| Vor Biopharma Inc. | 209.82 Million USD | -962.571% |
| Roivant Sciences Ltd. | 7.22 Billion USD | 69.13% |
| Evogene Ltd. | 51.1 Million USD | -4263.067% |
| ProKidney Corp. | 420.55 Million USD | -430.153% |
| Applied Therapeutics, Inc. | 54.83 Million USD | -3966.112% |
| Hoth Therapeutics, Inc. | 9.52 Million USD | -23319.18% |
| BridgeBio Pharma, Inc. | 546.38 Million USD | -308.062% |
| CorMedix Inc. | 82.05 Million USD | -2617.002% |
| BioLineRx Ltd. | 63.92 Million USD | -3387.792% |
| Tango Therapeutics, Inc. | 402.56 Million USD | -453.838% |
| Galectin Therapeutics Inc. | 28.2 Million USD | -7806.28% |
| Atai Life Sciences N.V. | 293.47 Million USD | -659.706% |
| Renovaro Biosciences Inc. | 163.12 Million USD | -1266.75% |
| Aerovate Therapeutics, Inc. | 127.41 Million USD | -1649.809% |
| Zentalis Pharmaceuticals, Inc. | 562.02 Million USD | -296.702% |
| Sagimet Biosciences Inc. | 96.71 Million USD | -2205.205% |
| MediciNova, Inc. | 66.26 Million USD | -3264.376% |
| Praxis Precision Medicines, Inc. | 87.94 Million USD | -2435.101% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -49863.887% |
| GeoVax Labs, Inc. | 9.28 Million USD | -23917.219% |
| Axsome Therapeutics, Inc. | 588.23 Million USD | -279.027% |
| Biomea Fusion, Inc. | 199.92 Million USD | -1015.193% |
| PTC Therapeutics, Inc. | 1.9 Billion USD | -17.15% |
| Mereo BioPharma Group plc | 66.49 Million USD | -3252.789% |
| Cullinan Oncology, Inc. | 485.09 Million USD | -359.614% |
| Syndax Pharmaceuticals, Inc. | 612.88 Million USD | -263.786% |
| Absci Corporation | 234.48 Million USD | -850.858% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -30379.44% |
| 4D Molecular Therapeutics, Inc. | 339.89 Million USD | -555.966% |
| Dyne Therapeutics, Inc. | 165.08 Million USD | -1250.584% |
| Kiniksa Pharmaceuticals, Ltd. | 526.32 Million USD | -323.613% |
| Ventyx Biosciences, Inc. | 277.69 Million USD | -702.891% |
| Allakos Inc. | 243.61 Million USD | -815.221% |
| Imunon, Inc. | 21.91 Million USD | -10072.297% |
| Fulcrum Therapeutics, Inc. | 257.69 Million USD | -765.201% |
| Corcept Therapeutics Incorporated | 621.51 Million USD | -258.73% |
| BioAtla, Inc. | 119.65 Million USD | -1763.286% |
| NLS Pharmaceutics AG | 1.84 Million USD | -120636.57% |
| Bio-Path Holdings, Inc. | 3.22 Million USD | -69141.335% |
| Allogene Therapeutics, Inc. | 642.83 Million USD | -246.833% |
| Larimar Therapeutics, Inc. | 95.93 Million USD | -2224.043% |
| XOMA Corporation | 234.3 Million USD | -851.584% |
| Kezar Life Sciences, Inc. | 221.23 Million USD | -907.784% |
| Cara Therapeutics, Inc. | 125.84 Million USD | -1671.694% |
| aTyr Pharma, Inc. | 122.06 Million USD | -1726.514% |
| Aligos Therapeutics, Inc. | 153.9 Million USD | -1348.686% |
| Akero Therapeutics, Inc. | 580.27 Million USD | -284.229% |
| Viridian Therapeutics, Inc. | 490.42 Million USD | -354.621% |
| Eliem Therapeutics, Inc. | 110.46 Million USD | -1918.278% |
| EyeGate Pharmaceuticals, Inc. | 15.15 Million USD | -14609.301% |
| Akari Therapeutics, Plc | 4.35 Million USD | -51095.66% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -12986.385% |
| Halozyme Therapeutics, Inc. | 1.73 Billion USD | -28.634% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -72195.108% |
| UroGen Pharma Ltd. | 178.31 Million USD | -1150.383% |
| Sutro Biopharma, Inc. | 470.73 Million USD | -373.635% |
| ZIVO Bioscience, Inc. | 555.71 Thousand USD | -401107.633% |
| Orgenesis Inc. | 14.55 Million USD | -15221.406% |
| Entera Bio Ltd. | 11.76 Million USD | -18850.88% |
| GH Research PLC | 226.3 Million USD | -885.228% |
| Lisata Therapeutics, Inc. | 54.69 Million USD | -3976.445% |
| Reneo Pharmaceuticals, Inc. | 107.43 Million USD | -1975.255% |
| Xencor, Inc. | 952.69 Million USD | -134.029% |
| 60 Degrees Pharmaceuticals, Inc. | 7.78 Million USD | -28543.841% |
| Replimune Group, Inc. | 487.72 Million USD | -357.14% |
| Coeptis Therapeutics Holdings, Inc. | 8.07 Million USD | -27524.166% |
| Vanda Pharmaceuticals Inc. | 648.44 Million USD | -243.836% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -72195.108% |
| Portage Biotech Inc. | 7.77 Million USD | -28561.409% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -49863.887% |
| Olema Pharmaceuticals, Inc. | 276.94 Million USD | -705.059% |
| OncoCyte Corporation | 74.89 Million USD | -2877.048% |
| Qualigen Therapeutics, Inc. | 2.03 Million USD | -109555.635% |
| Processa Pharmaceuticals, Inc. | 5.78 Million USD | -38429.61% |
| Purple Biotech Ltd. | 44.3 Million USD | -4932.664% |
| CollPlant Biotechnologies Ltd. | 34.12 Million USD | -6433.35% |
| scPharmaceuticals Inc. | 94.47 Million USD | -2259.859% |
| ProMIS Neurosciences, Inc. | 18.04 Million USD | -12255.645% |
| HilleVax, Inc. | 344.43 Million USD | -547.314% |
| NeuroSense Therapeutics Ltd. | 3.17 Million USD | -70100.598% |
| Tharimmune, Inc. | 10.94 Million USD | -20268.088% |
| Genprex, Inc. | 10.67 Million USD | -20794.539% |
| Neumora Therapeutics, Inc. Common Stock | 496.19 Million USD | -349.334% |
| Atossa Therapeutics, Inc. | 96.25 Million USD | -2216.389% |
| XTL Biopharmaceuticals Ltd. | 2.42 Million USD | -91803.174% |
| Virios Therapeutics, Inc. | 4.16 Million USD | -53425.449% |
| OKYO Pharma Limited | 1.54 Million USD | -144558.605% |
| Savara Inc. | 177.56 Million USD | -1155.644% |
| Curis, Inc. | 77.28 Million USD | -2784.981% |
| Daré Bioscience, Inc. | 21.28 Million USD | -10376.217% |
| Carmell Therapeutics Corporation | 63.94 Million USD | -3386.494% |
| Titan Pharmaceuticals, Inc. | 8.08 Million USD | -27473.225% |
| Achieve Life Sciences, Inc. | 19.37 Million USD | -11409.839% |
| BeiGene, Ltd. | 5.8 Billion USD | 61.594% |
| Kiromic BioPharma, Inc. | 12.16 Million USD | -18221.727% |
| Revolution Medicines, Inc. Warrant | 2.08 Billion USD | -6.75% |
| Protagonist Therapeutics, Inc. | 357.95 Million USD | -522.87% |
| Erasca, Inc. | 395.29 Million USD | -464.024% |
| bluebird bio, Inc. | 619.16 Million USD | -260.096% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -51470.222% |
| BioMarin Pharmaceutical Inc. | 6.84 Billion USD | 67.412% |
| DBV Technologies S.A. | 182.98 Million USD | -1118.438% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -51470.222% |
| Moderna, Inc. | 18.42 Billion USD | 87.9% |
| Vincerx Pharma, Inc. | 18.21 Million USD | -12138.958% |
| Fresh Tracks Therapeutics, Inc. | 11.58 Million USD | -19143.665% |
| Molecular Templates, Inc. | 35.38 Million USD | -6201.249% |
| Acrivon Therapeutics, Inc. Common Stock | 138.26 Million USD | -1512.535% |
| Travere Therapeutics, Inc. | 788.91 Million USD | -182.613% |
| Monte Rosa Therapeutics, Inc. | 303.75 Million USD | -634.003% |
| Spruce Biosciences, Inc. | 103.94 Million USD | -2044.932% |
| Celldex Therapeutics, Inc. | 465.62 Million USD | -378.832% |
| Cogent Biosciences, Inc. | 313.43 Million USD | -611.33% |
| MacroGenics, Inc. | 306.82 Million USD | -626.671% |
| RenovoRx, Inc. | 1.46 Million USD | -151985.334% |
| Adicet Bio, Inc. | 207.29 Million USD | -975.555% |
| Prime Medicine, Inc. | 193.85 Million USD | -1050.147% |
| Aditxt, Inc. | 44.57 Million USD | -4901.469% |
| Adagene Inc. | 115.72 Million USD | -1826.547% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -49955.599% |
| Quantum-Si incorporated | 298.25 Million USD | -647.551% |
| Maravai LifeSciences Holdings, Inc. | 1.48 Billion USD | -49.892% |
| Acurx Pharmaceuticals, Inc. | 7.7 Million USD | -28821.202% |
| Voyager Therapeutics, Inc. | 351.28 Million USD | -534.697% |
| SciSparc Ltd. | 11.18 Million USD | -19838.929% |
| Vericel Corporation | 353.65 Million USD | -530.433% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -18156.304% |
| Minerva Neurosciences, Inc. | 56.9 Million USD | -3818.36% |
| Generation Bio Co. | 374.75 Million USD | -494.936% |
| Astria Therapeutics, Inc. | 254.66 Million USD | -775.488% |
| Black Diamond Therapeutics, Inc. | 158.56 Million USD | -1306.075% |
| Arcutis Biotherapeutics, Inc. | 341.36 Million USD | -553.134% |
| Invivyd, Inc. | 229.18 Million USD | -872.843% |
| Relay Therapeutics, Inc. | 843.98 Million USD | -164.173% |
| Quoin Pharmaceuticals, Ltd. | 12.16 Million USD | -18221.274% |
| Spero Therapeutics, Inc. | 182.39 Million USD | -1122.42% |
| Artelo Biosciences, Inc. | 20.42 Million USD | -10816.427% |
| 2seventy bio, Inc. | 565.42 Million USD | -294.317% |
| ADMA Biologics, Inc. | 329.18 Million USD | -577.306% |
| Clene Inc. | 52.34 Million USD | -4159.703% |
| Capricor Therapeutics, Inc. | 58.73 Million USD | -3696.027% |
| Boundless Bio, Inc. Common Stock | 129.89 Million USD | -1616.454% |
| GeoVax Labs, Inc. | 9.28 Million USD | -23917.219% |
| Recursion Pharmaceuticals, Inc. | 653.69 Million USD | -241.07% |
| Citius Pharmaceuticals, Inc. | 103.61 Million USD | -2051.864% |
| Contineum Therapeutics, Inc. Class A Common Stock | 130.38 Million USD | -1609.977% |
| Relmada Therapeutics, Inc. | 97.55 Million USD | -2185.52% |
| Finch Therapeutics Group, Inc. | 70.99 Million USD | -3040.374% |
| ALX Oncology Holdings Inc. | 242.55 Million USD | -819.21% |
| Vir Biotechnology, Inc. | 1.96 Billion USD | -13.748% |
| Evaxion Biotech A/S | 12.88 Million USD | -17198.758% |
| Ocular Therapeutix, Inc. | 252.06 Million USD | -784.54% |
| Verve Therapeutics, Inc. | 752.68 Million USD | -196.215% |
| Trevena, Inc. | 40.6 Million USD | -5390.878% |
| Surrozen, Inc. | 46.08 Million USD | -4738.479% |
| Tyra Biosciences, Inc. | 225.85 Million USD | -887.16% |
| Cingulate Inc. | 3.49 Million USD | -63758.281% |
| Galmed Pharmaceuticals Ltd. | 16.62 Million USD | -13307.727% |
| Unity Biotechnology, Inc. | 65.69 Million USD | -3294.08% |
| Tenax Therapeutics, Inc. | 11.68 Million USD | -18981.234% |
| Terns Pharmaceuticals, Inc. | 268.51 Million USD | -730.328% |
| ACADIA Pharmaceuticals Inc. | 748.95 Million USD | -197.691% |
| Connect Biopharma Holdings Limited | 125.89 Million USD | -1671.019% |
| Clearmind Medicine Inc. | 4.32 Million USD | -51458.058% |
| Kronos Bio, Inc. | 213.27 Million USD | -945.378% |
| Bolt Biotherapeutics, Inc. | 159.78 Million USD | -1295.366% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -25944.534% |
| Viking Therapeutics, Inc. | 368.49 Million USD | -505.056% |
| Statera Biopharma, Inc. | 21.16 Million USD | -10431.904% |
| ImmunityBio, Inc. | 504.45 Million USD | -341.979% |
| Korro Bio, Inc. | 221.66 Million USD | -905.838% |
| Kineta, Inc. | 10.28 Million USD | -21586.324% |
| BioVie Inc. | 25.2 Million USD | -8744.575% |
| Codexis, Inc. | 136.56 Million USD | -1532.656% |
| Celularity Inc. | 143.88 Million USD | -1449.508% |
| Crinetics Pharmaceuticals, Inc. | 635.35 Million USD | -250.918% |
| Celcuity Inc. | 191.21 Million USD | -1065.975% |
| Virax Biolabs Group Limited | 5.48 Million USD | -40556.156% |
| Cibus, Inc. | 544.41 Million USD | -309.538% |
| Eledon Pharmaceuticals, Inc. | 125.89 Million USD | -1670.991% |
| eFFECTOR Therapeutics, Inc. | 20.54 Million USD | -10752.663% |
| IN8bio, Inc. | 33.7 Million USD | -6514.171% |
| Kodiak Sciences Inc. | 479.37 Million USD | -365.102% |
| Annexon, Inc. | 297.67 Million USD | -648.998% |
| Adverum Biotechnologies, Inc. | 173.01 Million USD | -1188.695% |
| Assembly Biosciences, Inc. | 137.46 Million USD | -1521.872% |
| Avalo Therapeutics, Inc. | 20.99 Million USD | -10520.545% |
| Ionis Pharmaceuticals, Inc. | 2.99 Billion USD | 25.434% |
| Eyenovia, Inc. | 28.77 Million USD | -7647.114% |
| Puma Biotechnology, Inc. | 230.52 Million USD | -867.158% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -30763.386% |
| Xilio Therapeutics, Inc. | 60.92 Million USD | -3559.474% |
| Arcellx, Inc. | 825.13 Million USD | -170.208% |
| Cardiff Oncology, Inc. | 81.63 Million USD | -2631.079% |
| Enanta Pharmaceuticals, Inc. | 462.27 Million USD | -382.304% |
| Regulus Therapeutics Inc. | 30.75 Million USD | -7150.637% |
| Moolec Science SA | 24.05 Million USD | -9170.069% |
| Acumen Pharmaceuticals, Inc. | 310.12 Million USD | -618.927% |
| Geron Corporation | 394.07 Million USD | -465.772% |
| LAVA Therapeutics N.V. | 101.71 Million USD | -2092.086% |
| Royalty Pharma plc | 16.38 Billion USD | 86.39% |
| Atea Pharmaceuticals, Inc. | 594.96 Million USD | -274.738% |
| Greenwich LifeSciences, Inc. | 6.99 Million USD | -31774.624% |
| TFF Pharmaceuticals, Inc. | 12.02 Million USD | -18437.561% |
| Mersana Therapeutics, Inc. | 226.06 Million USD | -886.274% |
| Humacyte, Inc. | 128.22 Million USD | -1638.823% |
| Structure Therapeutics Inc. | 482.01 Million USD | -362.55% |
| 89bio, Inc. | 596.26 Million USD | -273.92% |
| PMV Pharmaceuticals, Inc. | 252.15 Million USD | -784.217% |
| Avenue Therapeutics, Inc. | 1.85 Million USD | -120417.351% |
| Genelux Corporation | 27.89 Million USD | -7893.299% |
| Trevi Therapeutics, Inc. | 89.4 Million USD | -2393.844% |
| Lexicon Pharmaceuticals, Inc. | 229.42 Million USD | -871.791% |
| Notable Labs, Ltd. | 19.54 Million USD | -11309.708% |
| Liquidia Corporation | 120.43 Million USD | -1751.326% |
| Mustang Bio, Inc. | 17.74 Million USD | -12466.627% |
| Immunovant, Inc. | 666.71 Million USD | -234.413% |
| Quantum-Si incorporated | 298.25 Million USD | -647.551% |
| Arbutus Biopharma Corporation | 144.4 Million USD | -1444.014% |
| DiaMedica Therapeutics Inc. | 54.16 Million USD | -4016.638% |
| Vera Therapeutics, Inc. | 175.54 Million USD | -1170.078% |
| Acasti Pharma Inc. | 73.3 Million USD | -2941.707% |
| MiNK Therapeutics, Inc. | 4.55 Million USD | -48877.007% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -8436.904% |
| Xenon Pharmaceuticals Inc. | 964.79 Million USD | -131.092% |
| Elevai Labs, Inc. Common Stock | 5.18 Million USD | -42859.658% |
| NeuroBo Pharmaceuticals, Inc. | 22.78 Million USD | -9686.976% |
| Tempest Therapeutics, Inc. | 51.6 Million USD | -4220.623% |
| Soleno Therapeutics, Inc. | 180.69 Million USD | -1133.914% |
| PepGen Inc. | 143.05 Million USD | -1458.574% |
| Moleculin Biotech, Inc. | 38.21 Million USD | -5733.977% |
| United Therapeutics Corporation | 7.16 Billion USD | 68.891% |
| Nuvectis Pharma, Inc. | 19.18 Million USD | -11521.428% |
| Solid Biosciences Inc. | 164.93 Million USD | -1251.755% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -37867.846% |
| Immuneering Corporation | 102.58 Million USD | -2073.399% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -51646.754% |
| Silo Pharma, Inc. | 7.74 Million USD | -28682.99% |
| Belite Bio, Inc | 94.64 Million USD | -2255.794% |
| XOMA Corporation | 234.3 Million USD | -851.584% |
| ARS Pharmaceuticals, Inc. | 233.18 Million USD | -856.126% |
| Bionomics Limited | 27.64 Million USD | -7963.812% |
| Apogee Therapeutics, Inc. | 401.4 Million USD | -455.443% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -1976.183% |
| uniQure N.V. | 831.68 Million USD | -168.077% |
| Cassava Sciences, Inc. | 151.66 Million USD | -1370.082% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -49955.599% |
| Poseida Therapeutics, Inc. | 273.88 Million USD | -714.054% |
| Forte Biosciences, Inc. | 38.98 Million USD | -5619.782% |
| Anebulo Pharmaceuticals, Inc. | 4.07 Million USD | -54638.733% |
| Enlivex Therapeutics Ltd. | 36.83 Million USD | -5953.517% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -30763.386% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -63366.297% |
| FibroBiologics, Inc. Common Stock | 11.82 Million USD | -18761.103% |
| Altimmune, Inc. | 210.64 Million USD | -958.475% |
| Amicus Therapeutics, Inc. | 777.88 Million USD | -186.621% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -1976.183% |
| Compugen Ltd. | 121.33 Million USD | -1737.548% |
| Peak Bio, Inc. | 2.59 Million USD | -85771.134% |
| Zevra Therapeutics, Inc. | 172.32 Million USD | -1193.802% |
| Benitec Biopharma Inc. | 52.21 Million USD | -4170.391% |
| Spyre Therapeutics, Inc. | 341.85 Million USD | -552.19% |
| NKGen Biotech, Inc. Common Stock | 34.77 Million USD | -6311.788% |
| Zura Bio Limited | 100.84 Million USD | -2110.933% |
| PolyPid Ltd. | 15.37 Million USD | -14404.105% |
| Aileron Therapeutics, Inc. | 119.28 Million USD | -1769.097% |
| NKGen Biotech, Inc. Warrants | 34.77 Million USD | -6311.788% |
| Instil Bio, Inc. | 325.63 Million USD | -584.695% |
| argenx SE | 4.54 Billion USD | 50.917% |
| Immunome, Inc. | 148.54 Million USD | -1400.99% |
| Compass Therapeutics, Inc. | 156.87 Million USD | -1321.24% |
| Verona Pharma plc | 308.12 Million USD | -623.595% |
| enGene Holdings Inc. Warrants | 86.95 Million USD | -2463.934% |
| Shattuck Labs, Inc. | 159.56 Million USD | -1297.289% |
| CervoMed Inc. | 9.97 Million USD | -22257.145% |
| LENZ Therapeutics, Inc. | 188.45 Million USD | -1083.072% |
| Plus Therapeutics, Inc. | 11.38 Million USD | -19478.249% |
| Dianthus Therapeutics, Inc. | 179.4 Million USD | -1142.759% |
| Moolec Science SA | 24.05 Million USD | -9170.069% |
| Enveric Biosciences, Inc. | 6.11 Million USD | -36345.906% |
| Inovio Pharmaceuticals, Inc. | 172.94 Million USD | -1189.184% |
| AnaptysBio, Inc. | 452.38 Million USD | -392.844% |
| Design Therapeutics, Inc. | 289.64 Million USD | -669.765% |
| Leap Therapeutics, Inc. | 72.82 Million USD | -2961.546% |
| NeurAxis, Inc. | 509.49 Thousand USD | -437501.521% |
| Seelos Therapeutics, Inc. | 5.41 Million USD | -41051.181% |
| Lumos Pharma, Inc. | 40.63 Million USD | -5386.419% |
| Achilles Therapeutics plc | 161.45 Million USD | -1280.916% |
| enGene Holdings Inc. Common Stock | 86.95 Million USD | -2463.934% |
| 180 Life Sciences Corp. | 5.25 Million USD | -42291.504% |
| Opiant Pharmaceuticals, Inc. | 70.42 Million USD | -3065.754% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -25944.534% |
| Nutriband Inc. | 7.51 Million USD | -29559.775% |
| ORIC Pharmaceuticals, Inc. | 254.68 Million USD | -775.42% |
| CG Oncology, Inc. Common stock | 199.3 Million USD | -1018.695% |
| Fractyl Health, Inc. Common Stock | 76.21 Million USD | -2825.485% |
| Rani Therapeutics Holdings, Inc. | 57.91 Million USD | -3749.663% |
| MoonLake Immunotherapeutics | 526.54 Million USD | -323.438% |
| Palisade Bio, Inc. | 14.05 Million USD | -15766.574% |
| Tourmaline Bio, Inc. | 210.29 Million USD | -960.211% |
| Beam Therapeutics Inc. | 1.45 Billion USD | -52.74% |
| Neurogene Inc. | 222.57 Million USD | -901.726% |
| Mirum Pharmaceuticals, Inc. | 646.62 Million USD | -244.803% |
| AEON Biopharma, Inc. | 6.84 Million USD | -32472.257% |
| CARGO Therapeutics, Inc. Common Stock | 453.03 Million USD | -392.14% |
| Sesen Bio, Inc. | 189.17 Million USD | -1078.582% |
| Enliven Therapeutics, Inc. | 271.86 Million USD | -720.096% |
| Kiora Pharmaceuticals, Inc. | 13.71 Million USD | -16160.153% |
| Iovance Biotherapeutics, Inc. | 780.35 Million USD | -185.714% |
| Taysha Gene Therapies, Inc. | 266.99 Million USD | -735.064% |
| Athira Pharma, Inc. | 160.24 Million USD | -1291.351% |
| Vaccinex, Inc. | 3.63 Million USD | -61303.773% |
| HCW Biologics Inc. | 28.51 Million USD | -7719.308% |
| XOMA Corporation | 234.3 Million USD | -851.584% |
| Nektar Therapeutics | 398.03 Million USD | -460.147% |
| Arvinas, Inc. | 1.3 Billion USD | -70.901% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -12986.385% |
| Merus N.V. | 458.49 Million USD | -386.281% |
| Omega Therapeutics, Inc. | 204.36 Million USD | -990.97% |
| Quince Therapeutics, Inc. | 180.2 Million USD | -1137.248% |
| Rezolute, Inc. | 132.73 Million USD | -1579.691% |
| Clene Inc. | 52.34 Million USD | -4159.703% |
| Indaptus Therapeutics, Inc. | 14.92 Million USD | -14839.622% |
| BeyondSpring Inc. | 24.8 Million USD | -8887.307% |
| Synlogic, Inc. | 75.55 Million USD | -2851.12% |
| Allarity Therapeutics, Inc. | 11.86 Million USD | -18695.911% |
| Phio Pharmaceuticals Corp. | 9.36 Million USD | -23710.028% |
| Peak Bio, Inc. | 2.59 Million USD | -85771.134% |
| Werewolf Therapeutics, Inc. | 174.83 Million USD | -1175.258% |
| Krystal Biotech, Inc. | 818.35 Million USD | -172.445% |
| Karyopharm Therapeutics Inc. | 240.43 Million USD | -827.296% |
| SpringWorks Therapeutics, Inc. | 725.78 Million USD | -207.193% |
| Lipella Pharmaceuticals Inc. | 3.57 Million USD | -62227.72% |
| MannKind Corporation | 475.19 Million USD | -369.188% |
| Ikena Oncology, Inc. | 192.09 Million USD | -1060.679% |
| Cyclerion Therapeutics, Inc. | 13.37 Million USD | -16570.936% |
| Gyre Therapeutics, Inc. | 116.53 Million USD | -1813.154% |
| Gossamer Bio, Inc. | 311.91 Million USD | -614.799% |
| CohBar, Inc. | 16.36 Million USD | -13523.466% |
| Cognition Therapeutics, Inc. | 35.16 Million USD | -6240.673% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -30379.44% |
| Legend Biotech Corporation | 1.84 Billion USD | -20.608% |
| Mural Oncology plc | 301.74 Million USD | -638.892% |
| Biora Therapeutics, Inc. | 31.21 Million USD | -7042.627% |
| PaxMedica, Inc. Common Stock | 5.68 Million USD | -39150.212% |
| Disc Medicine, Inc. | 367.99 Million USD | -505.868% |
| Champions Oncology, Inc. | 26.13 Million USD | -8431.957% |
| REGENXBIO Inc. | 573.97 Million USD | -288.447% |
| Ensysce Biosciences, Inc. | 2.7 Million USD | -82230.171% |
| Anavex Life Sciences Corp. | 154.38 Million USD | -1344.154% |
| Cellectar Biosciences, Inc. | 12.07 Million USD | -18363.469% |
| Edgewise Therapeutics, Inc. | 340.03 Million USD | -555.689% |
| Vaxart, Inc. | 91.83 Million USD | -2327.933% |
| PharmaCyte Biotech, Inc. | 59.9 Million USD | -3621.914% |
| Aldeyra Therapeutics, Inc. | 148.32 Million USD | -1403.147% |
| Cellectis S.A. | 334.27 Million USD | -566.997% |
| Longeveron Inc. | 12.17 Million USD | -18208.187% |
| Repare Therapeutics Inc. | 253.9 Million USD | -778.126% |
| Sarepta Therapeutics, Inc. | 3.26 Billion USD | 31.704% |
| Inozyme Pharma, Inc. | 200.84 Million USD | -1010.084% |
| Revolution Medicines, Inc. | 2.08 Billion USD | -6.75% |
| Nymox Pharmaceutical Corporation | 1.62 Million USD | -137104.369% |
| Third Harmonic Bio, Inc. | 277.71 Million USD | -702.839% |
| ArriVent BioPharma, Inc. Common Stock | 163.09 Million USD | -1267.013% |
| AN2 Therapeutics, Inc. | 138.74 Million USD | -1506.968% |
| Anixa Biosciences, Inc. | 25.52 Million USD | -8635.879% |
| Vertex Pharmaceuticals Incorporated | 22.73 Billion USD | 90.191% |
| Denali Therapeutics Inc. | 1.15 Billion USD | -93.218% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -18156.304% |
| Veru Inc. | 50.59 Million USD | -4306.622% |
| Corvus Pharmaceuticals, Inc. | 45.55 Million USD | -4794.455% |
| Cingulate Inc. | 3.49 Million USD | -63758.281% |
| Passage Bio, Inc. | 150.54 Million USD | -1381.0% |
| Context Therapeutics Inc. | 16.06 Million USD | -13780.395% |
| Exicure, Inc. | 11.58 Million USD | -19153.636% |
| Day One Biopharmaceuticals, Inc. | 376.04 Million USD | -492.895% |
| Oramed Pharmaceuticals Inc. | 161.64 Million USD | -1279.327% |
| Scinai Immunotherapeutics Ltd. | 17.47 Million USD | -12660.823% |
| Rhythm Pharmaceuticals, Inc. | 332.74 Million USD | -570.054% |
| Nuvalent, Inc. | 732.38 Million USD | -204.427% |
| ABVC BioPharma, Inc. | 14.94 Million USD | -14819.427% |
| Carisma Therapeutics, Inc. | 89.55 Million USD | -2389.639% |
| Unicycive Therapeutics, Inc. | 14.19 Million USD | -15611.162% |
| OmniAb, Inc. | 401.98 Million USD | -454.64% |
| Anew Medical, Inc. | 19.45 Million USD | -11359.583% |
| Fennec Pharmaceuticals Inc. | 26.72 Million USD | -8242.156% |
| Lipocine Inc. | 23 Million USD | -9593.335% |
| Lexeo Therapeutics, Inc. Common Stock | 139.8 Million USD | -1494.749% |
| Nautilus Biotechnology, Inc. | 305.56 Million USD | -629.655% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -2556.109% |
| G1 Therapeutics, Inc. | 121.54 Million USD | -1734.434% |
| Bellerophon Therapeutics, Inc. | 7.93 Million USD | -27997.933% |
| Sage Therapeutics, Inc. | 882.27 Million USD | -152.706% |
| Ocugen, Inc. | 64.54 Million USD | -3354.182% |
| Mind Medicine (MindMed) Inc. | 124.54 Million USD | -1690.231% |
| Q32 Bio Inc. | 306.11 Million USD | -628.335% |
| Brainstorm Cell Therapeutics Inc. | 4.2 Million USD | -52884.102% |
| Alumis Inc. Common Stock | 89.61 Million USD | -2388.027% |
| Equillium, Inc. | 50.53 Million USD | -4312.371% |
| Kyverna Therapeutics, Inc. | 75.19 Million USD | -2865.052% |
| Coya Therapeutics, Inc. | 41.27 Million USD | -5301.94% |
| CNS Pharmaceuticals, Inc. | 1.7 Million USD | -130985.461% |
| Galera Therapeutics, Inc. | 26.14 Million USD | -8429.02% |
| Evelo Biosciences, Inc. | 64.44 Million USD | -3359.864% |
| Comera Life Sciences Holdings, Inc. | 3.72 Million USD | -59720.322% |
| Dominari Holdings Inc. | 57.55 Million USD | -3773.607% |
| Edesa Biotech, Inc. | 8.89 Million USD | -24978.306% |
| vTv Therapeutics Inc. | 11.01 Million USD | -20135.714% |
| Bio-Techne Corporation | 2.81 Billion USD | 20.746% |
| Agios Pharmaceuticals, Inc. | 937.11 Million USD | -137.918% |
| Harmony Biosciences Holdings, Inc. | 811.44 Million USD | -174.764% |
| Prelude Therapeutics Incorporated | 277.66 Million USD | -702.972% |
| Candel Therapeutics, Inc. | 41.7 Million USD | -5246.437% |
| iTeos Therapeutics, Inc. | 667.58 Million USD | -233.974% |
| Nkarta, Inc. | 378.88 Million USD | -488.456% |
| BioCardia, Inc. | 2.98 Million USD | -74542.484% |
| Iterum Therapeutics plc | 26.25 Million USD | -8390.693% |